REXO1

gene
On this page

Also known as EloA-BP1KIAA1138

Summary

REXO1 (RNA exonuclease 1 homolog, HGNC:24616) is a protein-coding gene on chromosome 19p13.3, encoding RNA exonuclease 1 homolog (Q8N1G1). Seems to have no detectable effect on transcription elongation in vitro.

Predicted to enable exonuclease activity. Predicted to be involved in rRNA 3’-end processing. Located in nuclear body.

Source: NCBI Gene 57455 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 284 total
  • MANE Select transcript: NM_020695

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24616
Approved symbolREXO1
NameRNA exonuclease 1 homolog
Location19p13.3
Locus typegene with protein product
StatusApproved
AliasesEloA-BP1, KIAA1138
Ensembl geneENSG00000079313
Ensembl biotypeprotein_coding
OMIM609614
Entrez57455

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 5 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000170168, ENST00000586291, ENST00000586343, ENST00000587404, ENST00000587524, ENST00000588743, ENST00000590936, ENST00000643515, ENST00000919437, ENST00000919438, ENST00000919439

RefSeq mRNA: 1 — MANE Select: NM_020695 NM_020695

CCDS: CCDS32866

Canonical transcript exons

ENST00000170168 — 16 exons

ExonStartEnd
ENSE0000065570418162251816345
ENSE0000065571118172191817329
ENSE0000089214818152481816154
ENSE0000089214918164311816569
ENSE0000163386018235721823785
ENSE0000166581418258391825943
ENSE0000168412818215191821682
ENSE0000175259618199341820057
ENSE0000230017018482021848483
ENSE0000271111318268781828631
ENSE0000351397318187061818843
ENSE0000358396418190181819131
ENSE0000365780118166981816813
ENSE0000372348318184821818595
ENSE0000374705918202641820395
ENSE0000374734918177071817780

Expression profiles

Bgee: expression breadth ubiquitous, 173 present calls, max score 97.78.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.2967 / max 193.3725, expressed in 1757 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
1780747.65181749
1780750.6024312
1780700.02733
1780690.00763
1780680.00503
1780710.00252

Top tissues by expression

228 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right testisUBERON:000453497.78gold quality
left testisUBERON:000453397.63gold quality
right adrenal gland cortexUBERON:003582795.64gold quality
right adrenal glandUBERON:000123395.35gold quality
left adrenal gland cortexUBERON:003582594.84gold quality
left adrenal glandUBERON:000123494.80gold quality
testisUBERON:000047394.04gold quality
adrenal cortexUBERON:000123593.36gold quality
spleenUBERON:000210693.19gold quality
mucosa of transverse colonUBERON:000499193.08gold quality
skin of legUBERON:000151192.81gold quality
sural nerveUBERON:001548892.58gold quality
granulocyteCL:000009492.47gold quality
adrenal glandUBERON:000236992.36gold quality
right frontal lobeUBERON:000281092.33gold quality
skin of abdomenUBERON:000141692.24gold quality
apex of heartUBERON:000209891.77gold quality
right lobe of liverUBERON:000111491.71gold quality
lower esophagus mucosaUBERON:003583491.47gold quality
transverse colonUBERON:000115791.45gold quality
right hemisphere of cerebellumUBERON:001489091.38gold quality
left uterine tubeUBERON:000130391.22gold quality
right lungUBERON:000216791.13gold quality
small intestine Peyer’s patchUBERON:000345491.03gold quality
putamenUBERON:000187490.90gold quality
upper lobe of left lungUBERON:000895290.77gold quality
right ovaryUBERON:000211890.70gold quality
anterior cingulate cortexUBERON:000983590.64gold quality
left ovaryUBERON:000211990.51gold quality
cerebellar hemisphereUBERON:000224590.51gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.98

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

43 targeting REXO1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4283100.0066.422097
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-5692A100.0074.406850
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-32-5P99.9875.211964
HSA-MIR-92A-3P99.9875.211960
HSA-MIR-92B-3P99.9875.251955
HSA-MIR-25-3P99.9874.601817
HSA-MIR-363-3P99.9874.721821
HSA-MIR-367-3P99.9874.831819
HSA-MIR-185-3P99.9567.011743
HSA-MIR-449299.8768.253611
HSA-MIR-137-3P99.8774.742401
HSA-MIR-6756-5P99.8267.972466
HSA-MIR-6739-5P99.8067.872806
HSA-MIR-6733-5P99.7467.942759
HSA-MIR-6752-3P99.7266.711587
HSA-MIR-6766-5P99.6867.702325
HSA-MIR-7-5P99.6770.531809
HSA-MIR-76299.5866.611994
HSA-MIR-315399.5567.592337
HSA-MIR-448999.5065.56785
HSA-MIR-449899.4767.422360
HSA-MIR-6722-3P99.4567.621919
HSA-MIR-450599.2767.812678
HSA-MIR-578799.2267.862628
HSA-MIR-429199.2068.882969
HSA-MIR-328-5P99.0864.651000
HSA-MIR-371A-5P99.0866.511914
HSA-MIR-5001-5P99.0566.761972

Literature-anchored findings (GeneRIF, showing 3)

  • cloning and characterization of a novel human exonuclease domain-containing protein, Elongin A-binding protein 1; it is capable of binding not only the NH(2)-terminal approximately 120 amino acid region of Elongin A, but also that of SII (PMID:12943681)
  • These findings showed that REX1 regulates the proliferation/differentiation of human mesenchymal stem cells through the suppression of p38 MAPK signaling via the direct suppression of MKK3. (PMID:20463961)
  • Loss of REX1 expression demarcates stable, OCT4-positive lineage pluripotent human embryonic stem cells. (PMID:23437358)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusRexo1ENSMUSG00000047417
rattus_norvegicusRexo1ENSRNOG00000017916

Paralogs (5): REXO5 (ENSG00000005189), ISG20L2 (ENSG00000143319), REXO4 (ENSG00000148300), ISG20 (ENSG00000172183), AEN (ENSG00000181026)

Protein

Protein identifiers

RNA exonuclease 1 homologQ8N1G1 (reviewed: Q8N1G1)

Alternative names: Elongin-A-binding protein 1, Transcription elongation factor B polypeptide 3-binding protein 1

All UniProt accessions (4): Q8N1G1, A0A087WY50, A0A2R8Y7I5, K7ESH4

UniProt curated annotations — full annotation on UniProt →

Function. Seems to have no detectable effect on transcription elongation in vitro.

Subunit / interactions. Interacts with TCEA2 and ELOA.

Subcellular location. Nucleus.

Tissue specificity. Ubiquitously expressed.

Similarity. Belongs to the REXO1/REXO3 family.

RefSeq proteins (1): NP_065746* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR012337RNaseH-like_sfHomologous_superfamily
IPR013520Ribonucl_HDomain
IPR031736REXO1-like_domDomain
IPR034922REX1-like_exoDomain
IPR036397RNaseH_sfHomologous_superfamily
IPR047021REXO1/3/4-likeFamily

Pfam: PF15870

UniProt features (28 total): modified residue 9, compositionally biased region 6, region of interest 5, sequence variant 4, chain 1, domain 1, sequence conflict 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N1G1-F159.130.20

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (9): 191, 287, 289, 358, 459, 499, 526, 610, 914

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 106 (showing top): GOBP_RIBOSOME_BIOGENESIS, GOMF_NUCLEASE_ACTIVITY, YY1_Q6, YY1_02, GOBP_RRNA_3_END_PROCESSING, CONRAD_STEM_CELL, GOMF_EXONUCLEASE_ACTIVITY, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GATGKMRGCG_UNKNOWN, GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, GCCATNTTG_YY1_Q6, GOCC_NUCLEAR_BODY, chr19p13, AAGWWRNYGGC_UNKNOWN, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS

GO Biological Process (1): rRNA 3’-end processing (GO:0031125)

GO Molecular Function (4): nucleic acid binding (GO:0003676), exonuclease activity (GO:0004527), nuclease activity (GO:0004518), hydrolase activity (GO:0016787)

GO Cellular Component (3): nucleus (GO:0005634), nucleoplasm (GO:0005654), nuclear body (GO:0016604)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
rRNA processing1
RNA 3’-end processing1
binding1
nuclease activity1
hydrolase activity, acting on ester bonds1
catalytic activity, acting on a nucleic acid1
catalytic activity1
intracellular membrane-bounded organelle1
nuclear lumen1
cellular anatomical structure1
nucleoplasm1
intracellular membraneless organelle1

Protein interactions and networks

STRING

1568 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
REXO1ELOAQ14241918
REXO1TCEA1P23193739
REXO1ELOA2Q8IYF1693
REXO1POLR2AP24928553
REXO1EML3Q32P44430
REXO1REXO2Q9Y3B8426
REXO1DDX51Q8N8A6409
REXO1SCAMP4Q969E2401
REXO1SKIC8Q9GZS3401
REXO1ZNF276Q8N554400
REXO1C19orf25Q9UFG5396
REXO1DUS3LQ96G46384
REXO1LEO1Q8WVC0383
REXO1VPS9D1Q9Y2B5379
REXO1PPIEQ9UNP9371

IntAct

10 interactions, top by confidence:

ABTypeScore
REXO1H3-4psi-mi:“MI:0915”(physical association)0.400
REXO1UBA52psi-mi:“MI:0915”(physical association)0.400
DGCR6REXO1psi-mi:“MI:0915”(physical association)0.400
Rprd1bPOLR2Bpsi-mi:“MI:0914”(association)0.350
AP2M1C1orf226psi-mi:“MI:0914”(association)0.350
SSRP1DDX39Apsi-mi:“MI:0914”(association)0.350
SMNDC1SMCHD1psi-mi:“MI:2364”(proximity)0.270
PAFAH1B2REXO1psi-mi:“MI:0915”(physical association)0.000

BioGRID (22): REXO1 (Affinity Capture-MS), TCEB3 (Affinity Capture-Western), TCEB3 (Reconstituted Complex), REXO1 (Two-hybrid), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS), REXO1 (Two-hybrid), REXO1 (Proximity Label-MS), REXO1 (Proximity Label-MS), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS)

ESM2 similar proteins: A2A7S8, A5D7K1, A5PK23, B1AXH1, F1QGH6, O94885, O95402, Q08495, Q08DM1, Q3T044, Q499V8, Q5HYW2, Q5PQP4, Q5R4B6, Q5R8Q8, Q5SYE7, Q5T0Z8, Q5U2R6, Q6PDH0, Q6PFX7, Q6PGN9, Q6ZVC0, Q7TT28, Q80U35, Q80VC9, Q80Z38, Q86UU1, Q86WR7, Q8BI29, Q8C5R2, Q8CAF4, Q8JZX9, Q8K4J6, Q8N1G1, Q8TF72, Q91Z58, Q969V6, Q96A73, Q9BW04, Q9D0P7

Diamond homologs: A1A5R7, A1Z7K9, A3KPE8, A3LRV8, A4RF51, A5DAD0, A5E1W0, B2GUW6, G0SAK8, O94375, O94443, P0C581, P0CQ08, P0CQ09, P0CQ44, P0CQ45, P48778, P53010, P53015, P53331, Q08237, Q09798, Q0CJU7, Q10124, Q2GSV2, Q2T9U5, Q2YDK1, Q3U1G5, Q4PER6, Q4R9F7, Q4WYA1, Q504Q3, Q54U94, Q5AL29, Q5APK0, Q5B367, Q5F450, Q5REE2, Q6AXU3, Q6C462

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

284 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance243
Likely benign17
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

3516 predictions. Top by Δscore:

VariantEffectΔscore
19:1816453:T:Adonor_gain1.0000
19:1816694:ACAC:Adonor_loss1.0000
19:1816697:C:CGdonor_loss1.0000
19:1816809:TAGGA:Tacceptor_gain1.0000
19:1816810:AGGA:Aacceptor_gain1.0000
19:1816811:GGA:Gacceptor_gain1.0000
19:1816812:GA:Gacceptor_gain1.0000
19:1816814:C:CCacceptor_gain1.0000
19:1816814:CTGC:Cacceptor_loss1.0000
19:1816815:T:Gacceptor_loss1.0000
19:1816817:C:CTacceptor_gain1.0000
19:1816818:G:Tacceptor_gain1.0000
19:1817214:CTCA:Cdonor_loss1.0000
19:1817215:TCACC:Tdonor_loss1.0000
19:1817216:CACC:Cdonor_loss1.0000
19:1817217:A:ACdonor_gain1.0000
19:1817217:A:Tdonor_loss1.0000
19:1817218:C:CCdonor_gain1.0000
19:1817218:C:CGdonor_loss1.0000
19:1817218:CCAT:Cdonor_gain1.0000
19:1817325:TGTTG:Tacceptor_gain1.0000
19:1817326:GTTG:Gacceptor_gain1.0000
19:1817327:T:Cacceptor_gain1.0000
19:1817327:TTG:Tacceptor_gain1.0000
19:1817328:TG:Tacceptor_gain1.0000
19:1817330:C:CAacceptor_loss1.0000
19:1817330:C:CCacceptor_gain1.0000
19:1817336:G:Cacceptor_gain1.0000
19:1817336:G:GCacceptor_gain1.0000
19:1817702:CTCA:Cdonor_loss1.0000

AlphaMissense

7855 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:1816109:A:GL1208P1.000
19:1816109:A:TL1208Q1.000
19:1816117:G:CC1205W1.000
19:1816118:C:TC1205Y1.000
19:1816263:A:GL1180P1.000
19:1816308:A:GF1165S1.000
19:1816324:C:GD1160H1.000
19:1816444:A:GL1148P1.000
19:1816463:G:CH1142D1.000
19:1816465:C:AG1141V1.000
19:1816465:C:TG1141E1.000
19:1816466:C:GG1141R1.000
19:1816466:C:TG1141R1.000
19:1816471:A:TL1139H1.000
19:1816566:A:CF1107L1.000
19:1816566:A:TF1107L1.000
19:1816568:A:GF1107L1.000
19:1817225:G:CC1065W1.000
19:1819993:G:TA864D1.000
19:1820325:A:GL822P1.000
19:1820338:G:TR818S1.000
19:1816119:A:GC1205R0.999
19:1816127:G:TA1202D0.999
19:1816128:C:GA1202P0.999
19:1816129:G:CD1201E0.999
19:1816129:G:TD1201E0.999
19:1816130:T:CD1201G0.999
19:1816130:T:GD1201A0.999
19:1816131:C:GD1201H0.999
19:1816139:G:AS1198F0.999

dbSNP variants (sampled 300 via entrez): RS1000110872 (19:1843433 G>A,C,T), RS1000140903 (19:1850149 T>C), RS1000372648 (19:1829621 C>A,T), RS1000417486 (19:1849884 G>A,T), RS1000444525 (19:1838163 T>A), RS1000507651 (19:1841724 C>A,T), RS1000537001 (19:1841494 G>A), RS1000540379 (19:1841337 C>G,T), RS1000609783 (19:1820176 T>C,G), RS1000655468 (19:1818330 GC>G), RS1000722711 (19:1837295 C>A), RS1000777255 (19:1841307 C>T), RS1000807287 (19:1845309 C>T), RS1000843656 (19:1832793 G>A), RS1000946179 (19:1832515 C>G,T)

Disease associations

OMIM: gene MIM:609614 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST008129_31Body mass index2.000000e-11
GCST010774_10Essential hypertension (time to event)4.000000e-08
GCST90002396_6Mean reticulocyte volume1.000000e-18
GCST90002397_396Mean spheric corpuscular volume7.000000e-24

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0004918age at diagnosis
EFO:0010701mean reticulocyte volume

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

24 total (human), top 24 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression2
aristolochic acid Iincreases expression1
FR900359increases phosphorylation1
dicrotophosincreases expression1
bufotalinincreases expression1
triphenyl phosphateaffects expression1
benzo(e)pyreneincreases methylation1
cupric chlorideincreases expression1
beta-methylcholineaffects expression1
fipronildecreases expression1
abrineincreases expression1
Air Pollutantsaffects expression, increases abundance1
Atrazineincreases expression1
Caffeineincreases phosphorylation1
Doxorubicindecreases expression1
Methapyrileneincreases methylation1
Ozoneaffects expression, increases abundance1
Smokedecreases expression1
Dronabinolincreases expression1
Thiramincreases expression1
Urethaneincreases expression1
Aflatoxin B1increases methylation1
Cadmium Chlorideincreases expression1
p-Chloromercuribenzoic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): essential hypertension